| Revenue growth | 31.5% like-for-like growth in FY26, outperforming market by 1.6x. |
|---|---|
| Margins | EBITDA margins expanded 67bps YoY to 4% via better product mix. |
| Demand visibility | Strong visibility across pharma and diagnostics; expanding into new medical segments. |
| Management confidence | Balanced and confident, emphasizing transition from M&A to organic execution. |
Growth
Growth was driven by 31.5% organic like-for-like revenue increase and aggressive MedTech expansion contributing ₹1,000cr annually.
Outlook
FY27 guidance: 23% consolidated revenue growth and 5% EBITDA margins without new acquisitions.
Risks
High minority interest impacts PAT; working capital remains sensitive to MedTech's longer payable cycles.
Earnings Call filed with NSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,733.10
- Market cap
- ₹7,543 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 60.1×Sector 53.1×
- Promoter holding
- 52.40%-0.02% QoQ
- FII holding
- 4.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Entero Healthcare Solutions Capital Structure Change
Prasid Uno Family Trust acquired 10,88,500 shares (2.50%) of Entero Healthcare Solutions Ltd via a block deal. Post-transaction, their total stake is 6.93%.
Entero Healthcare Solutions Management Change
Entero Healthcare Solutions announced the completion of the tenure of Non-Executive Independent Director Mr. Rajesh Shashikant Dalal, effective from August 24, 2026.
Entero Healthcare Solutions Annual General Meeting
Entero Healthcare Solutions Ltd held its 8th Annual General Meeting on August 19, 2026. Members approved all resolutions, including financial statement adoption and director re-appointments.